Headlines

Sarah Wynn-Williams—Meta whistleblower and author of the recently released book “Careless People”—testified before the U.S. Senate April 9 about many of the company’s negative business practices.

Jazz Pharmaceuticals has agreed to pay $145 million to resolve antitrust litigation alleging pay-for-delay tactics with popular narcolepsy drug Xyrem®.

Our client lost their livelihood after being diagnosed with nonarteritic anterior ischemic optic neuropathy (NAION). Despite stopping Ozempic, they remain legally blind.

A tourist helicopter lost control and plunged into the Hudson River on April 10, 2025, claiming the lives of a family of five and the pilot.

A civil lawsuit has been filed in California federal court seeking to hold the Sinaloa Cartel and it's indicted drug kingpins responsible for the DEA special agent Kiki Camarena's brutal kidnap and murder in 1985.

A federal lawsuit was filed today against Delta Air Lines, Inc., and its subsidiary Endeavor Air, following the crash landing of Delta Flight 4819 at Toronto Pearson International Airport on Feb. 17, 2025.

American Airlines Flight 5342 collided midair with an Army Black Hawk helicopter on January 29, 2025. Learn more here.

Motley Rice attorneys representing Matthew Heath and Osman Khan sued Venezuelan President Nicolas Maduro and 16 other defendants on January 6, 2025 in federal court.

Motley Rice, one of the nation’s largest plaintiffs’ litigation firms, has filed a multicount lawsuit against Global Blood Therapeutics, Inc. (GBT), alleging its prescription drug Oxbryta® (voxelotor) caused the tragic death of 39-year-old Marissa Harris in August 2021.

The U.S. Securities and Exchange Commission (SEC) has granted an award of more than $6 million to two whistleblowers represented by Motley Rice LLC for the pair’s role in safeguarding investors and upholding market integrity.